January 16, 2025

FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension

Mineralys Therapeutics receives FDA clearance for a phase II clinical trial investigating lorundrostat, an aldosterone synthase inhibitor, in patients with moderate-to-severe obstructive sleep apnea and hypertension.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

FDA Proposes Nicotine Limits for Tobacco

The US Food and Drug Administration has introduced a proposal to cap nicotine levels in cigarettes, with the goal of curbing addiction, reducing smoking rates, and averting millions of tobacco-related deaths by 2100.

Conexiant

January 15, 2025

Can Wearables Help Manage Moderate Sleep Apnea Without CPAP?

Researchers are conducting the Moore4Medical trial to evaluate whether an eHealth intervention, consisting of a wrist device and a mobile application, can effectively manage blood pressure, sleep quality, and physical activity levels in adult patients with moderate obstructive sleep apnea and hypertension.

Conexiant

January 13, 2025

Genetic Links Between MDD and Diseases

"Our findings confirmed the extensive and significant causal role of genetic predisposition to MDD in contributing to human disease phenotypes."

Conexiant

January 09, 2025

Medicare Covers Tirzepatide for Sleep Apnea

Eli Lilly's tirzepatide gets Medicare coverage for sleep apnea, widening access to weight-loss treatment. Are obesity drugs getting a breakthrough?

Reuters

January 08, 2025

Modified Consent May Aid Psychedelic Trials

Researchers at the University of California, San Francisco propose modifications to informed consent procedures in psychedelic drug trials, aiming to balance scientific rigor and ethical standards.

Conexiant

January 06, 2025

FDA Drafts New Pulse Oximeter Rules

"Our draft recommendations are based on the best available science to help address concerns of disparate performance of pulse oximeters based on an individual's skin pigmentation."

Conexiant

January 06, 2025

Low Birth Weight, Maternal Smoking Raise COPD Risk

‘The lowest birth weight group faced a 21% higher COPD risk,’ researchers reveal.

Conexiant